2013 International Symposium on PI-PLC Activity and signaling at UNIST

The UNIST Center for Cell to Cell Communication in Cancers (C5) will host an international conference on Phosphatidylinositol-Specific Phospholipase C (PI-PLC) Activity and Signaling which will be held on July 18 ~ 19 at Ulsan National Institute of Science and Technology (UNIST), Ulsan, Korea.



Cell to cell communication constitutes an essential process for the growth and division of a cell, that is under tight control by numerous growth factor-dependent signals. Failure of this communication leads to uncontrolled cell growth and cancer.



Over 200 world-wide scholars, experts, researchers, and students are invited to the international conference. Lucio Cocco from University Bologna, Kioko Fukami from Tokyo University of Pharmacy and Life Science, Sue Goo Rhee from Yonsei University, and Yoe-Sik Bae from Sungkyunkwan University, are included in the invited speakers.



Director of C5, and Vice President for Research Affaire Pann-Ghill Suh from UNIST, Korea, and Lucio Cocco from University of Bologna, Italy, are organizing this international symposium. They will discuss various concerns in PLC signaling, including PLC and PLC-related regulation mechanism with the world’s most distinguished scholars in this area.



A special speaker, Prof. Sue Goo Rhee, as the first discoverer of core elements in cell to cell communication, will talk about the history of PI-PLC research, and the future responsibility of the research. He has been known as one of the strongest Korean candidates of Nobel Prize in the field of cell to cell communication.



“Discovering the factors affecting the communication is, therefore, essential in understanding the role of cell to cell communication in cancer progression and blue-ocean in the area of developing new bio medicine,” said Prof. Suh, Vice President for Research Affaires. “Identifying the novel factors in cell to cell communication and characterizing their molecular mechanisms give insight into cancer cells development and metastasis, which maximize our ability to diagnose and treat cancer.”